Krawczyk Piotr, Morawski Marcin, Krasnodębski Maciej, Sieńko Damian, Grąt Michał, Kron Philipp, Lodge Peter
Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, 02-097 Warsaw, Poland.
Department of HPB and Transplant Surgery, St. James' University Hospital, Leeds LS9 7TF, UK.
J Clin Med. 2021 Jun 24;10(13):2778. doi: 10.3390/jcm10132778.
The use of the Pringle maneuver (PM) varies widely among surgical departments. Its use depends on the operator and type of liver resection. The aim of this study was to determine the impact of the PM on patient outcomes when undergoing major liver resections. This retrospective study comprised 179 colorectal liver metastasis patients from two liver centers from Leeds and Warsaw. Only right or right extended hepatectomies with negative oncological margins were included. The primary outcome measure was the 5-year overall survival (OS). The PM was applied during 60 (33.5%) major hepatectomies included in the study and was associated with a higher peak 3-day postoperative bilirubin concentration ( = 0.002), yet not with the peak 3-day alanine aminotransferase activity ( = 0.415). The 5-year OS after liver resections with the PM and without the PM were 55.0% and 33.4%, respectively ( = 0.019). Following stratification by the Tumor Burden Score, after resections with the use of the PM, superior survival was particularly found in the subgroup of patients at intermediate risk of recurrence ( = 0.004). However, the use of the PM had no significant effect on the 5-year overall survival following adjustment for the confounding effect of the carcinoembryonic antigen concentration ( = 0.265). The use of the PM had no negative effects on the long-term outcomes in patients undergoing major, oncologically radical liver resections for colorectal metastases.
普林格尔手法(PM)在各外科科室的使用差异很大。其使用取决于操作者和肝切除术的类型。本研究的目的是确定PM对接受大肝切除术患者预后的影响。这项回顾性研究纳入了来自利兹和华沙两个肝脏中心的179例结直肠癌肝转移患者。仅纳入切缘阴性的右半肝切除术或右半肝扩大切除术。主要结局指标是5年总生存率(OS)。在纳入研究的60例(33.5%)大肝切除术中应用了PM,其与术后3天胆红素峰值浓度较高相关(P = 0.002),但与术后3天丙氨酸转氨酶峰值活性无关(P = 0.415)。使用PM和未使用PM的肝切除术后5年OS分别为55.0%和33.4%(P = 0.019)。根据肿瘤负荷评分进行分层后,在使用PM进行切除术后,尤其在复发中度风险亚组患者中发现了更好的生存率(P = 0.004)。然而,在调整癌胚抗原浓度的混杂效应后,PM的使用对5年总生存率没有显著影响(P = 0.265)。PM的使用对接受结直肠癌肝转移大的、肿瘤根治性肝切除术患者的长期预后没有负面影响。